Description
Biostatistical and eClinical Services for phase I to IV clinical trials
Established for more than 25 years, IDDI has grown as a leading provider in the design, collection, reporting and analysis of clinical trial data.
International Drug Development Institute (IDDI) optimizes the clinical development of drugs, biomarkers and devices using a unique combination of advanced biostatistics and innovative integrated data collection technology.
IDDI is a science-driven technology company combining medical and clinical expertise, advanced biostatistics and regulatory experience with innovative integrated web systems to increase efficiency throughout the drug development process and mitigate risks associated with clinical trials.
Its highly skilled professionals deliver state of the art services including:
Its therapeutic areas of expertise include oncology, ophthalmology, infectious diseases, cardiology, auto-immune, orphan drugs and biosimilars.
Our experience spans 25+ years with 800+ trials and 16 FDA/EMA approvals to-date.
IDDI is based in Belgium - EU, with offices in Cambridge MA, Raleigh NC, San Francisco CA, USA.
Established for more than 25 years, IDDI has grown as a leading provider in the design, collection, reporting and analysis of clinical trial data.
International Drug Development Institute (IDDI) optimizes the clinical development of drugs, biomarkers and devices using a unique combination of advanced biostatistics and innovative integrated data collection technology.
IDDI is a science-driven technology company combining medical and clinical expertise, advanced biostatistics and regulatory experience with innovative integrated web systems to increase efficiency throughout the drug development process and mitigate risks associated with clinical trials.
Its highly skilled professionals deliver state of the art services including:
- Trial design
- Clinical trial program strategy
- Protocol design
- Expert mission with regulatory agencies
- Randomization (IWRS) and drug supply management integrated with our EDC
- (e)CRF design, data management and medical coding
- Statistical services
- Statistical analyses
- IDMCs and interim analyses
- Key Risk Indicators
- Meta-analyses
- Biomarker/Diagnostics Validation
- Central Statistical Monitoring
- Medical Writing
- Consulting services
- Strategic & global drug development consulting services
- System integration and inter-operability consulting services
- Monitoring, Regulatory Affairs and Pharmacovigilance through our partnerships
Its therapeutic areas of expertise include oncology, ophthalmology, infectious diseases, cardiology, auto-immune, orphan drugs and biosimilars.
Our experience spans 25+ years with 800+ trials and 16 FDA/EMA approvals to-date.
IDDI is based in Belgium - EU, with offices in Cambridge MA, Raleigh NC, San Francisco CA, USA.
Contact
Website: www.iddi.com
